NASDAQ : ZNTL

Zentalis Pharmaceuticals, Inc. — Earnings Estimates

$4.22 USD

-$0.78 (-15.6%)

Volume
1.58M
Average Volume
1.17M
Market Capitalization
$300.41M
P/E Ratio
-1.72
Dividend Yield
0.00%
Price Target
$10.00
Year High
$6.95
Year Low
$1.21
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$4.82

Annual earnings financials

ZNTL financial data with annual/quarterly toggle

ZNTL GAAP EPS - Annual & Quarterly

ZNTL Sales Revenue - Annual & Quarterly

ZNTL Shares Outstanding - Annual & Quarterly

Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.

ZNTL Estimated and Actual Revenue by Quarter
ZNTL Estimated and Actual EPS by Quarter
ZNTL Analyst Forecasts — EBITDA & EBIT
Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2027-12-30 1 7.41M 7.41M 7.41M 7.41M 7.41M 7.41M
2027-09-30 1 3.14M 3.14M 3.14M 3.14M 3.14M 3.14M
2027-06-30 1 890.4K 890.4K 890.4K 890.4K 890.4K 890.4K
2027-03-30 0 - - - - - -
2026-12-30 0 - - - - - -
2026-09-30 0 - - - - - -
ZNTL Analyst Forecasts — Net Income & SGA Expense
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2027-12-30 1 -24.59M -24.59M -24.59M 13.07M 13.07M 13.07M
2027-09-30 1 -28.11M -28.11M -28.11M 5.53M 5.53M 5.53M
2027-06-30 1 -29.65M -29.65M -29.65M 1.57M 1.57M 1.57M
2027-03-30 0 -28.81M -28.81M -28.81M - - -
2026-12-30 0 -30.98M -30.98M -30.98M - - -
2026-09-30 0 -40.96M -26.59M -35.21M - - -
ZNTL Analyst Forecasts — Revenue & EPS
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2027-12-30 1 12.34M 12.34M 12.34M 2 -0.35 -0.35 -0.35
2027-09-30 1 5.23M 5.23M 5.23M 2 -0.4 -0.4 -0.4
2027-06-30 1 1.48M 1.48M 1.48M 2 -0.422 -0.422 -0.422
2027-03-30 0 - - - 2 -0.41 -0.41 -0.41
2026-12-30 0 - - - 2 -0.44096 -0.44096 -0.44096
2026-09-30 0 - - - 6 -0.58292 -0.37839 -0.50111